Try it
Psychiatry · Substance use
Sample itemA man with opioid dependence is stabilised on buprenorphine-naloxone sublingual tablets. Which statement about buprenorphine explains why it is safer than methadone in overdose?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
B. It is a partial mu-agonist with a ceiling effect on respiratory depression
Buprenorphine is a high-affinity partial agonist at the mu receptor and an antagonist at the kappa receptor. Its partial agonism produces a ceiling on respiratory depression, which lowers overdose risk. Its high affinity and slow dissociation also allow once-daily or less frequent dosing, but it can precipitate withdrawal if given to a patient with full agonists on board.
Option by option
A. It is a full mu-agonist with a very short half-life
Buprenorphine is a partial agonist with a long duration of action, so this is incorrect.
B. It is a partial mu-agonist with a ceiling effect on respiratory depression (correct)
Correct. Partial agonism leads to a ceiling effect on respiratory depression.
C. It is a pure mu-antagonist that blocks all opioid effects
A pure antagonist describes naltrexone, which is not an agonist maintenance drug.
D. It is a kappa agonist that does not affect respiration
Buprenorphine acts as a kappa antagonist, and its safety does not come from kappa agonism.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.